Study | Group | n | Age (range)/year | M:F | Level (NO.) | Correction of lordosis /° | Follow up (range) /Month | Complication (NO.) |
---|---|---|---|---|---|---|---|---|
Lazennec 15 | SPO | 19 | 43.5 (32–61) | 26:5 | T12-L1 (1); L2-L3 (7); L3-L4 (9); L4-L5 (2) | 41.1 ± 5.8 | - | Dural tear (4); Translation of caudal segment (5); Anterior cortex (1); Unstable fixation (4); Transient neural injury (6); paralysis (1); Narrowing of vertebral canal (1) |
PSO | 12 | L1 (1); L2 (7); L3 (4) | 47.4 ± 4.5 | Nonunion (1); Transient neural symptom (3); Secondary displacement (2) | ||||
Qiu 20 | PWO | 23 | 36 (25–56) | 49:5 | T12-L4 (23) | 44 ± 12 | 20 (11–45) | Dural tear (1); Pedicle fractures (1); Insufficient folding (4) |
PSO | 31 | L2 or L3 (31) | 36 ± 19 | Dural tear (1); Insufficient folding (2); Transient neural symptom (2) | ||||
Willems 27 | PWO | 20 | 46.1 (21–82) | 88:22 | - | - | 12 | Dural tear (5); Pedicle fractures (1); Insufficient folding (2); Deep infection (3); Neural damage (1); Instrumentation failure (4); |
PSO | 62 | Dural tear (12); Pedicle fractures (4); Superficial infection (4); Deep infection (5); Neural damage (6); Instrumentation failure (10); othersa (8) | ||||||
Cho 5 | SPO | 16 | 40.1 ± 11 | 23:7 | Single (7); Double (9) | 24.9 ± 10.6 | 55.2 (24–276) | Dural tear (1); DVT (1); Transient neural symptom (1); Superficial infection (3); Deep infection (1); Sagittal imbalance (4); nonunion (3) |
PWO | 14 | Triple (9); quadruple (3); quintuple (2) | 33.0 ± 9.2 | |||||
PSO | 41 | 54.5 ± 11.7 | 33:8 | - | 31.7 ± 9.0 | 49.4 (24–85.2) | Dural tear (3); DVT (2); Transient neural symptom (3); Superficial infection (1); nonunion (3); othersb (3) | |
Chang 4 | SPO | 66 | 34.8 (17–55) | 102:15 | L1-L2 (5); L2-L3 (55); L2-L4 (6) | 40 ± 14 | 43.2 (25.2-63.6) | Dural tear (4); Superficial infection (1); Transient neural symptom (3); Nonunion (3); Screw loosing (1); Kyphosis aggravation (2); othersc (13) |
Study | Group | n | Age (range) /year | M:F | Level (No.) | Correction of lordosis /° | Follow up (range)/Month | Complication (No.) |
Chang 4 | PSO | 51 | 34.8 (17–55) | 102:15 | L2 (47); L3 (4) | 38 ± 11 | 43.2 (25.2-63.6) | Dural tear (3); Superficial infection (1); Transient neural symptom (3); Nonunion (3); Screw loosing (3); Kyphosis aggravation (3); othersc (4) |
Zhu 29 | PWO | 32 | 35.2 (22–60) | 29:3 | T11-L4 (8); T12-L4 (21); T12-L5 (3) | 39.1 ± 7.8 | At least 3 | Dural tear (4); Screw loosing (2); Transient neural symptom (1); othersd (5) |
PSO | 61 | 37.8 (20–86) | 53:8 | T12 (2); L1 (11); L2 (30); L3 (18) | 37.1 ± 3.8 | Dural tear (1); Screw loosing (3); Secondary displacement (2); Fatal Bleeding > 4000 ml (5); Transient neural symptom (4); othersd (5) | ||
Arun1 | SPO | 10 | 54.7 (40–74) | 26:5 | L3-L4 (10) | 19 ± 11.6 | 60 (24–240) | Dural tear (2); Aorta damage (1); Nerve root injury (1); nonunion (1); Epidural hematoma (1) |
PWO | 9 | L2-L5 (9) | 30 ± 6.2 | Dural tear (1); Superficial infection (1); Epidural hematoma (1) | ||||
PSO | 12 | L3 (12) | 38 ± 5.4 | Dural tear (1); Nerve root injury (1); Superficial infection (1); Epidural hematoma (1) | ||||
Zhu30 | PWO | 19 | 27 (21–40) | 16:3 | T11-L4 (4); T12-L4 (14); T12-L5 (1) | 38.6 ± 12.8 | At least 12 | Dural tear (2); Transient neural symptom (1); |
PSO | 31 | 36 (22–54) | 26:5 | L1 (9); L2 (14);L3 (8) | 42.6 ± 15.7 | Dural tear (1); Transient neural symptom (3); Neural damage (1) |